Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7082)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2021 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rebelos E, Iozzo P, Guzzardi MA, Brunetto MR, Bonino F. Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease. World J Gastroenterol 2021; 27(30): 4999-5018 [PMID: 34497431 DOI: 10.3748/wjg.v27.i30.4999] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i30/4999.htm |
| Number | Citing Articles |
| 1 |
Boris Mravec, Maria Szantova. The role of the nervous system in liver diseases. Hepatology Research 2024; 54(11): 970 doi: 10.1111/hepr.14125
|
| 2 |
Vance L. Albaugh, Yanlin He, Heike Münzberg, Christopher D. Morrison, Sangho Yu, Hans-Rudolf Berthoud. Regulation of body weight: Lessons learned from bariatric surgery. Molecular Metabolism 2023; 68: 101517 doi: 10.1016/j.molmet.2022.101517
|
| 3 |
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, Adriano Cressoni Araújo, Ricardo de Alvares Goulart, Marcelo Dib Bechara, Lucas Fornari Laurindo, Nahum Méndez-Sánchez, Sandra Maria Barbalho. Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. International Journal of Molecular Sciences 2024; 25(7): 3694 doi: 10.3390/ijms25073694
|
| 4 |
So Yeong Cheon, Juhyun Song. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation. Cell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00836-0
|
| 5 |
Taylor J. Kelty, Ryan J. Dashek, W. David Arnold, R. Scott Rector. Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration. Seminars in Liver Disease 2023; 43(01): 077 doi: 10.1055/s-0043-1762585
|
| 6 |
Johannes R. Hov, Tom H. Karlsen. The microbiota and the gut–liver axis in primary sclerosing cholangitis. Nature Reviews Gastroenterology & Hepatology 2023; 20(3): 135 doi: 10.1038/s41575-022-00690-y
|
| 7 |
Jessica Zúñiga-Hernández, Camila Farias, Alejandra Espinosa, Lorena Mercado, Alexies Dagnino-Subiabre, Andrea del Campo, Paola Illesca, Luis A. Videla, Rodrigo Valenzuela. Modulation of Δ5- and Δ6-desaturases in the brain-liver axis. Nutrition 2024; : 112629 doi: 10.1016/j.nut.2024.112629
|
| 8 |
Yoon-su Ha, Taek-Kyong Kim, Jun Heo, Jintaek Oh, Seung-Kyoon Kim, Jeongkyu Kim, Jeonghyung Lee, Se-Ran Yang, Seonghwan Hwang, Seung-Jin Kim. Rocaglamide-A mitigates LPS-induced hepatic inflammation by modulating JNK/AP-1 signaling cascade and ROS production in hepatocytes. Toxicological Research 2024; doi: 10.1007/s43188-024-00263-y
|
| 9 |
Miikka-Juhani Honka, Eleni Rebelos, Simona Malaspina, Pirjo Nuutila. Hepatic Positron Emission Tomography: Applications in Metabolism, Haemodynamics and Cancer. Metabolites 2022; 12(4): 321 doi: 10.3390/metabo12040321
|
| 10 |
Amin Arif, Adil Farooq, Muddasir Hassan Abbasi, Muhammad Babar Khawar, Tasleem Akhtar, Humaira Allay Ali, Mehreen Anjum, Rabia Mehmood, Tayyaba Saleem, Nadeem Sheikh. Effect of heterologous platelet-rich plasma on liver and modulation of glucose metabolism and Wnt signalling pathways in diabetic mice. Molecular Biology Reports 2023; 50(9): 7145 doi: 10.1007/s11033-023-08600-4
|
| 11 |
Pengfei Lv, Hongzeng Li, Xiangbo Li, Xueyuying Wang, Jiantong Yu, Yanling Gong. Intestinal perfusion of unacylated ghrelin alleviated metabolically associated fatty liver disease in rats via a central glucagon-like peptide-1 pathway. American Journal of Physiology-Gastrointestinal and Liver Physiology 2024; 326(6): G643 doi: 10.1152/ajpgi.00217.2023
|
| 12 |
Zhisheng Chen, Mengxin Chen, Ping Zeng, Xiaobo Yang, Qian Li. Association of aspirin with all-cause and cardiocerebrovascular mortality in patients with metabolic associated fatty liver disease. Scandinavian Journal of Gastroenterology 2023; 58(8): 908 doi: 10.1080/00365521.2023.2179864
|
| 13 |
Maurizia R. Brunetto, Antonio Salvati, Giovanni Petralli, Ferruccio Bonino. Nutritional intervention in the management of non-alcoholic fatty liver disease. Best Practice & Research Clinical Gastroenterology 2023; : 101830 doi: 10.1016/j.bpg.2023.101830
|